Drug Type Molecular glue−antibody conjugate |
Synonyms- |
Target |
Action inhibitors, degraders |
Mechanism CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors), GSPT1 degraders(G1 to S phase transition 1 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
CD33-positive Acute Myeloid Leukemia | Preclinical | South Korea | 27 Apr 2025 |